Chance Pharmaceuticals

Chance Pharmaceuticals is engaged in the discovery, development, and commercialization of inhalation therapies aimed at treating serious diseases, including chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders. The company specializes in the development of generic drugs that utilize dry powder inhalation delivery systems. This innovative approach allows for cost-effective manufacturing by improving the technology behind powder aerosols, making it more accessible for researchers and ultimately benefiting patients with debilitating respiratory conditions.